Table 2.
Demographics and clinical characteristics of patients enrolled in SECAR trial.
| Characteristic | Patients (N = 34) | |
|---|---|---|
| No. | % | |
| Age, Years | ||
| Mean | 59.7 | |
| SD | 11 | |
| Median | 61.5 | |
| Range | 37–79 | |
| Sex | ||
| Male | 19 | 56 |
| Female | 15 | 44 |
| WHO performance status | ||
| 0 | 9 | 26.5 |
| 1 | 19 | 55.9 |
| 2 | 6 | 17.6 |
| Primary tumor types | ||
| Non-small cell lung carcinoma | 21 | 61.8 |
| Small-cell lung carcinoma | 3 | 8.8 |
| Colon cancer | 4 | 11.8 |
| Rectal cancer | 2 | 5.9 |
| Malignant mesothelioma | 1 | 2.9 |
| Ethmoidal cancer | 1 | 2.9 |
| Tongue base cancer | 1 | 2.9 |
| Testicular teratoma | 1 | 2.9 |
| Stages | ||
| Stage I | 0 | 0 |
| Stage II | 0 | 0 |
| Stage III | 7 | 20.6 |
| Stage IV | 27 | 79.4 |
| Refractory to first line therapy | 34 | 100 |
Abbreviations: WHO—World Health Organization; SD—Standard Deviation.